BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Altamira Therapeutics Ltd.

Headquarters: Zug, Switzerland
Year Founded: 2003
Status: Public
Industry Sector: HealthTechnology
CEO: Thomas Meyer, PhD
Number Of Employees: 13
Enterprise Value: $-324,601
PE Ratio: -0.02
Exchange/Ticker 1: OTCQB:CYTOF
Exchange/Ticker 2: N/A
Latest Market Cap: $405,800

BioCentury | Jul 30, 2024
Product Development

Venturing beyond AAVs and LNPs to deliver therapeutic cargo

Dozens of companies aim to avoid immunogenicity and improve tissue-specificity
Items per page:
1 - 1 of 1